Treating diabetic peripheral neuropathic pain

American Family Physician

Volumn 82, Issue 2, 2010, Pages 151-158

  Lindsay, Tammy J ^a   Rodgers, Blake C ^a   Savath, Vincent ^a   Hettinger, Kevin ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTICONVULSIVE AGENT; CAPSAICIN; CARBAMAZEPINE; CITALOPRAM; DEXAMETHASONE; DULOXETINE; EFAVIRENZ; GABAPENTIN; LAMOTRIGINE; LIDOCAINE; METHADONE; NORTRIPTYLINE; OPIATE; OXYCODONE; PAROXETINE; PHENOBARBITAL; PHENYTOIN; PLACEBO; PREGABALIN; RIFAMPICIN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRAMADOL; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; 4 AMINOBUTYRIC ACID; ANTIDEPRESSANT AGENT; DRUG DERIVATIVE; NARCOTIC ANALGESIC AGENT; THIOPHENE DERIVATIVE;

ALTERNATIVE MEDICINE; ANOREXIA; ARTICLE; ATAXIA; BEDTIME DOSAGE; COMBINATION CHEMOTHERAPY; CONFUSION; CONSTIPATION; COUGHING; DIABETIC NEUROPATHY; DIABETIC PERIPHERAL NEUROPATHIC PAIN; DIARRHEA; DIZZINESS; DOSE RESPONSE; DROWSINESS; DRUG ACTIVITY; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG EXCRETION; DRUG INDUCED HEADACHE; DRUG MEGADOSE; DRUG POTENTIATION; DRUG RELEASE; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; EDEMA; EMOTION; ENERGY; EXERCISE TOLERANCE; FATIGUE; FLATULENCE; HEART ARRHYTHMIA; HEART FAILURE; HEART INFARCTION; HUMAN; IMPOTENCE; INSOMNIA; LABORATORY TEST; META ANALYSIS; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; MYALGIA; NAUSEA; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHINOPHARYNGITIS; RISK FACTOR; SIDE EFFECT; SINUSITIS; SKIN DISEASE; SKIN IRRITATION; SLEEP; SOMNOLENCE; STEVENS JOHNSON SYNDROME; SWEATING; SYSTEMATIC REVIEW; TOXIC EPIDERMAL NECROLYSIS; TRANSDERMAL PATCH; VOMITING; WEIGHT GAIN; XEROSTOMIA; CONVALESCENCE; DRUG COMBINATION; DRUG INTERACTION; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; REVIEW;

ANALGESICS, OPIOID; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS; COMPLEMENTARY THERAPIES; DIABETIC NEUROPATHIES; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; GAMMA-AMINOBUTYRIC ACID; HUMANS; PAIN; PAIN MEASUREMENT; RECOVERY OF FUNCTION; THIOPHENES;

EID: 77955494873     PISSN: 0002838X     EISSN: 0002838X     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Barrett AM, Lucero MA, Le T, Robinson RL, Dworkin RH, Chappell AS. Epidemiology, public health burden, and treatment of diabetic peripheral neuropathic pain: a review. Pain Med. 2007;8(suppl 2):S50-S62.
2. Veves A, Backonja M, Malik RA. Painful diabetic neuropathy: epidemiology, natural history, early diagnosis, and treatment options. Pain Med. 2008;9(6):660-674.
3. Lee JH, Cox DJ, Mook DG, McCarty RC. Effect of hyperglycemia on pain threshold in alloxan-diabetic rats. Pain. 1990;40(1):105-107.
4. Wong MC, Chung JW, Wong TK. Effects of treatments for symptoms of painful diabetic neuropathy: systematic review. BMJ. 2007;335(7610):87.
5. Sultan A, Gaskell H, Derry S, Moore RA. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurol. 2008;8:29.
6. Argoff CE, Backonja MM, Belgrade MJ, et al. Diabetic peripheral neuropathic pain: consensus guidelines for treatment. J Fam Pract. 2006;(suppl):1-19. http://www.jfponline.com/uploadedFiles/Journal_Site_Files/Journal_of_Family_Practice/supplement_archive/Suppl_DPNP.pdf. Accessed March 31, 2009.
7. Argoff CE, Backonja MM, Belgrade MJ, et al. Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain [published correction appears in Mayo Clin Proc. 2006;81(6):854]. Mayo Clin Proc. 2006;81(4 suppl):S12-S25.
8. Saarto T, Wiffen PJ. Antidepressants for neuropathic pain. Cochrane Database Syst Rev. 2007;(4):CD005454.
9. Vinik A. Clinical review: use of antiepileptic drugs in the treatment of chronic painful diabetic neuropathy. J Clin Endocrinol Metab. 2005;90(8):4936-4945.
10. Freeman R, Durso-Decruz E, Emir B. Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of doses. Diabetes Care. 2008;31(7):1448-1454.
11. Wiffen PJ, McQuay HJ, Rees JE, Moore RA. Gabapentin for acute and chronic pain. Cochrane Database Syst Rev. 2005;(3):CD005452.
12. Wiffen PJ, McQuay HJ, Moore RA. Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev. 2005;(3):CD005451.
13. Wernicke JF, Pritchett YL, D'Souza DN, et al. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology. 2006;67(8):1411-1420.
14. Eisenberg E, McNicol E, Carr DB. Opioids for neuropathic pain. Cochrane Database Syst Rev. 2006;(3):CD006146.
15. Gilron I, Bailey JM, Tu D, Holden RR, Weaver DF, Houlden RL. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005;352(13):1324-1334.
16. Watson CP, Moulin D, Watt-Watson J, Gordon A, Eisenhoffer J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain. 2003;105(1-2):71-78.
17. Gimbel JS, Richards P, Portenoy RK. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology. 2003;60(6):927-934.
18. Hollingshead J, Dühmke RM, Cornblath DR. Tramadol for neuropathic pain. Cochrane Database Syst Rev. 2006;(3):CD003726.
19. Mason L, Moore RA, Derry S, Edwards JE, McQuay HJ. Systematic review of topical capsaicin for the treatment of chronic pain. BMJ. 2004;328(7446):991.
20. Meier T, Wasner G, Faust M, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain. 2003;106(1-2):151-158.
21. Barbano RL, Herrmann DN, Hart-Gouleau S, Pennella-Vaughan J, Lodewick PA, Dworkin RH. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol. 2004;61(6):914-918.
22. Sima AA, Calvani M, Mehra M, Amato A; Acetyl-L-Carnitine Study Group. Acetyl-L-carnitine improves pain, nerve regeneration, and vibratory perception in patients with chronic diabetic neuropathy: an analysis of two randomized placebo-controlled trials. Diabetes Care. 2005;28(1):89-94.
23. Ziegler D, Hanefeld M, Ruhnau KJ, et al. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a 7-month multicenter randomized controlled trial (ALADIN III Study). ALADIN III Study Group. Alpha-Lipoic Acid in Diabetic Neuropathy. Diabetes Care. 1999;22(8):1296-1301.
24. Hamza MA, White PF, Craig WF, et al. Percutaneous electrical nerve stimulation: a novel analgesic therapy for diabetic neuropathic pain. Diabetes Care. 2000;23(3):365-370.
25. Ahn AC, Bennani T, Freeman R, Hamdy O, Kaptchuk TJ. Two styles of acupuncture for treating painful diabetic neuropathy-a pilot randomised control trial. Acupunct Med. 2007;25(1-2):11-17.
26. Zhao T, Zhang R, Zhao H. Acupuncture for symptomatic treatment of diabetic peripheral neuropathy (Protocol). Cochrane Database Syst Rev. 2006;(4):CD006280.
27. Kumar D, Alvaro MS, Julka IS, Marshall HJ. Diabetic peripheral neuropathy. Effectiveness of electrotherapy and amitriptyline for symptomatic relief. Diabetes Care. 1998;21(8):1322-1325.
28. Bosi E, Conti M, Vermigli C, et al. Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy. Diabetologia. 2005;48(5):817-823.
29. Dubinsky RM, Miyasaki J. Assessment: efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2010;74(2):173-176.
30. Max MB, Culnane M, Schafer SC, et al. Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood. Neurology. 1987;37(4):589-596.
31. Benbow S, Wallymahmed M, MacFarlane IA. Diabetic peripheral neuropathy and quality of life. QJM. 1998;91(11):733-737.
32. Vieweg WV, Wood MA, Fernandez A, Beatty-Brooks M, Hasnain M, Pandurangi AK. Proarrhythmic risk with antipsychotic and antidepressant drugs: implications in the elderly. Drugs Aging. 2009;26(12):997-1012.
33. Berger A, Dukes E, Edelsberg J, Stacey B, Oster G. Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathy. Clin J Pain. 2007;23(3):251-258.
34. Thienel U, Neto W, Schwabe SK, Vijapurkar U; Topiramate Diabetic Neuropathic Pain Study Group. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand. 2004;110(4):221-231.
35. Wiffen PJ, Rees J. Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev. 2007;(2):CD006044.
36. Standaert DG, Young AB. Treatment of central nervous system degenerative disorders. In: Hardman JG, Limbird LE, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 10th ed. New York, NY: McGraw-Hill; 2001:533.
37. Tegretol (carbamazepine) [package insert]. East Hanover, N.J.: Novartis Pharmaceuticals Corporation; 2008.
38. Paton C, Procter AW. Carbamazepine monitoring. Psychiatr Bull. 1993;17(12):718-720.
39. Kochar DK, Rawat N, Agrawal RP, et al. Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study. QJM. 2004;97(1):33-38.
40. Rowbotham MC, Goli V, Kunz NR, Lei D. Venlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled study [published correction appears in Pain. 2005;113(1-2):248]. Pain. 2004;110(3):697-706.
41. Chou R, Fanciullo GJ, Fine PG, et al.; American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009;10(2):113-130.
42. Chang G, Chen L, Mao J. Opioid tolerance and hyperalgesia. Med Clin North Am. 2007;91(2):199-211.
43. Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain. 2008;24(6):469-478.
44. Harati Y, Gooch C, Swenson M, et al. Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998;50(6):1842-1846.
45. Ametov AS, Barinov A, Dyck PJ, et al.; SYDNEY Trial Study Group. The sensory symptoms of diabetic polyneuropathy are improved with alpha-lipoic acid: the SYDNEY trial [published correction appears in Diabetes Care. 2003;26(7):2227]. Diabetes Care. 2003;26(3):770-776.
46. Lexi-Comp [online reference library]. Hudson, Ohio: American Pharmaceutical Association; 2009. Updated daily. http://online.lexi.com (subscription required). Accessed October 27, 2009.
47. Boyer EW, Shannon M. The serotonin syndrome [published corrections appear in N Engl J Med. 2009;361(17):1714 and N Engl J Med. 2007;356:(23):2437]. N Engl J Med. 2005;352(11):1112-1120.
48. Gore M, Sadosky A, Leslie D, Sheehan AH. Selecting an appropriate medication for treating neuropathic pain in patients with diabetes: a study using the U.K. and Germany Mediplus databases. Pain Pract. 2008;8(4):253-262.